PHARMALIFE ApS

Q: What is the CVR number of PHARMALIFE ApS?

PHARMALIFE ApS is registered with CVR / Virk under CVR 45134490.

Q: What is the gross profit of PHARMALIFE ApS?

PHARMALIFE ApS reported a gross profit of -DKK 33.1k in 2025.

Q: Where is PHARMALIFE ApS headquartered?

PHARMALIFE ApS's registered address is Nordbaggevej 12.

APSActiveAdvertising protection

CVR 45134490Nordbaggevej 12, 8960 Randers SØRetail sale of cosmetic and toilet articles· NACE 4775Est. 2024 · 1 year old— employees

Overview

PHARMALIFE ApS is a Danish APS based in Randers SØ, operating in the Retail sale of cosmetic and toilet articles sector. Incorporated in 2024, the company reported a gross profit of -DKK 33.1k in its latest annual filing.

Gross profit 2025

-33.1K DKK

EBITDA margin (of gross profit)

100.0 %

Net profit 2025

-36.1K DKK

Key ratios

See full ratios →

1.7 %

Weak

Among the 30% lowest rated companies in the industry

20252025

17.6×

Very strong

Among the 10% highest rated companies in the industry

20252025

-15.9 %

Very weak

Among the 20% lowest rated companies in the industry

20252025

EBITDA — year on year

DKK thousands

Key figures

Annual report 2025

Gross profit	-33.1K DKK	—
EBITDA	-33.1K DKK	—
Net profit	-36.1K DKK	—
Total assets	227.5K DKK	—
Equity	3.9K DKK	—
Employees	—	—

Contact

Address

Nordbaggevej 12, 8960 Randers SØ

Advertising protection

Active — opted out of marketing use

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Financial development

In its most recent annual report (2025), PHARMALIFE ApS reported a gross profit of -DKK 33.1k. The bottom line showed a net loss of DKK 36.1k.

At the end of 2025, equity financed 1.7% of the balance sheet, and current assets covered short-term debt 17.6 times.

Financials

Gross profit

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2025
Gross profit	-33
Staff expenses	-0
EBITDA	-33
Depreciation & amort.	-0
EBIT	-33
Net financials	-3
Profit before tax	-36
Tax	-0
Net profit	-36

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2025
Total assets	227
Equity	4
Long-term debt	211
Short-term debt	13
Total debt	224

Financial ratios

5-year trend

EBITDA margin (of gross profit)

<−999 %

20252025

Equity ratio

1.7 %

Weak

Among the 30% lowest rated companies in the industry

20252025

Return on equity

-933.3 %

Very weak

Among the 10% lowest rated companies in the industry

20252025

Net profit margin (of gross profit)

<−999 %

20252025

Asset turnover (of gross profit)

-0.15×

20252025

Debt / equity

57.77×

Very weak

Among the 10% lowest rated companies in the industry

20252025

Sector performance

18 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on equity (ROE)Very weak

Among the 10% lowest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Very weak

Among the 20% lowest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Very weak

Among the 10% lowest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Very weak

Among the 20% lowest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Capacity ratioNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioVery strong

Among the 10% highest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioVery strong

Among the 20% highest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioVery strong

Among the 10% highest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityVery weak

Among the 10% lowest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalVery strong

Among the 10% highest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioWeak

Among the 30% lowest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioWeak

Among the 30% lowest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioWeak

Among the 30% lowest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityVery weak

Among the 10% lowest rated companies in the industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityVery weak

Among the 10% lowest rated companies in the industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtVery weak

Among the 20% lowest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery weak

Among the 20% lowest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery weak

Among the 20% lowest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Equity to contributed capitalWeak

Among the 30% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

One-year change in equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The size of this year's increase or decrease in the company's equity.

One-year change in debtNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The size of this year's increase or decrease in the company's debt.

Annual reports & filings

Annual report 2025
Filed via CVR / Virk · Period 2024-10-07 – 2025-09-30
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since
Current (1)
JL Jacob Larsen Management	Management	2024

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Jacob Larsen	Individual	100%	100%	2024

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of PHARMALIFE ApS also hold positions in 14 other companies.

Person	Role here	Other companies
Jacob Larsen	Management	14 companiesMany roles

Frequently asked questions

What is the CVR number of PHARMALIFE ApS?

PHARMALIFE ApS is registered with CVR / Virk under CVR 45134490.

What is the gross profit of PHARMALIFE ApS?

PHARMALIFE ApS reported a gross profit of -DKK 33.1k in 2025.

Where is PHARMALIFE ApS headquartered?

PHARMALIFE ApS's registered address is Nordbaggevej 12.